1987
Chronic Neuroleptic Effects on Dopamine Neuron Activity: A Model for Predicting Therapeutic Efficacy and Side Effects?
Freeman A, Bunney B. Chronic Neuroleptic Effects on Dopamine Neuron Activity: A Model for Predicting Therapeutic Efficacy and Side Effects? Psychopharmacology Series 1987, 3: 225-235. PMID: 2881290, DOI: 10.1007/978-3-642-71288-3_26.Peer-Reviewed Original ResearchConceptsMost psychotic patientsDA receptor blockerTreatment of choiceDopamine neuron activityCentral catecholamine systemsReceptor blockadeReceptor blockersCatecholamine neuronsNeuroleptic effectsMajor symptomsAntipsychotic drugsCatecholamine systemsAntipsychotic propertiesForebrain regionsNeuronal activityCatecholamine receptorsSide effectsDopamine systemNeuron activityPsychotic patientsTherapeutic efficacyMode of actionFeedback pathwaysTreatmentNeuroleptics
1974
A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons
Bunney B, Aghajanian G. A comparison of the effects of chlorpromazine, 7-hydroxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons. Life Sciences 1974, 15: 309-318. PMID: 4549921, DOI: 10.1016/0024-3205(74)90221-5.Peer-Reviewed Original ResearchConceptsChlorpromazine sulfoxideSingle-unit recording techniquesAnti-psychotic propertyCentral dopaminergic neuronsVentral tegmental neuronsPossible clinical importanceEffect of chlorpromazineA10 neuronsDopaminergic neuronsAntipsychotic efficacyPlasma levelsTegmental neuronsAntipsychotic agentsTherapeutic effectAntipsychotic propertiesClinical importanceEquivalent dosesRecording techniquesChlorpromazineNeuronsDepressionPreliminary studyPrevious findingsSulfoxide levelsChlorpromazine metabolites